my country's "Guidelines for Psoriasis grass -roots diagnosis and treatment" is released!The standardized diagnosis and treatment of county -level hospitals will "have chapters to follow"

As a "boss difficulty" disease in the field of dermatology, psoriasis needs to be "broken" and requires chronic disease management, and adheres to long -term treatment. Limited to the awareness of psoriasis at grassroots doctors, patients generally fail to get timely and accurate diagnosis and treatment. In order to break the "sleepy" of the grass -roots diagnosis and treatment of psoriasis, and improve the standardized diagnosis and treatment level of grass -roots levels, on September 17, under the guidance of the National Health and Health Commission Talent Exchange and Service Center and the National Remote Medical and Internet Medical Center, Suzhou University and China Medical Equipment Society Hosted, organized by Suzhou University Affiliated Dushu Lake Hospital, key laboratory of the Ministry of Dermatology Education, the General Medicine Branch of the Chinese Medical Association, Suzhou Medical Association, and Changshu City Health and Health Commission, Novartis support "Qianxian Silver Night Promise Chinese series of activities- "Guidelines for Psoriasis Grass-Clan Diagnosis and Treatment" (2022) and "Primary Doctors' Standardized Diagnosis and Treatment Projects" and "Application Guide for Slow Disease Management Research Research Projects" were officially released in Changshu, Jiangsu The standardized diagnosis and treatment of psoriasis can follow.

The "sleepy" of grass -roots diagnosis and treatment

75%of patients with psoriasis psoriasis are in grassroots hospitals in the county

Data show that about 7 million people in my country are plagued by psoriasis, most of which are concentrated in the county, and more than 75%of the first patients come from grass -roots medical institutions, but they are limited by grassroots doctors' recognition of psoriasis on psoriasis. Knowing the level, patients generally fail to get timely and accurate diagnosis.

In terms of treatment, from previous topical drugs, phototherapy to systemic drugs, the treatment of psoriasis is rich. With the deepening of the basic research on the disease, biological preparations and small molecular targeted drugs for pathogenic inflammation factors are developed as new targeted drugs for treating psoriasis. In recent years, it has benefited from the accelerated approval of innovative drugs and the implementation of medical insurance. The availability of these new targeted drugs has been greatly improved in many large and medium cities in my country. Patients with psoriasis are expected to have normal skin and even achieve "clinical cure", but At the grassroots level of the county, the treatment of psoriasis still faces multiple dilemma.

Due to the limited coverage of medical insurance at the grass -roots level, and most grass -roots doctors' professional knowledge updates are not timely, and the safety and efficacy of new targeting drugs are insufficient. At present, only a few grass -roots patients can benefit from precise targeted therapy. Professor Lu Qianjin, director of the Institute of Dermatology of the Chinese Academy of Medical Sciences, said, "New targeted drugs such as biologics such as biological agents are still insufficient in the vast county. Patients cannot obtain clinical benefits brought by innovative drugs, nor can they enjoy This is a pity that the physical and mental health brought by the medical insurance policy is very regrettable. "

It is key to break the "sleep" of psoriasis grass -roots diagnosis and treatment to help more county patients "cure" psoriasis. It is the key to start from the grassroots. Professor Zhang Xujun, chairman of the Psoriasis Branch of the Chinese Medical Association Dermatology Branch, and Dermatology Department of Dushu Lake Hospital affiliated to Suzhou University, said: "Grassroots dermatologists are the earliest, most, and widest doctors in patients with psoriasis, so they are at the grassroots level. The standardized diagnosis and treatment management of psoriasis is very necessary. Only by raising the level of diagnosis and treatment can more county patients be treated in a timely, effective and high -quality treatment. "

"Grassroots Guide" release

The standardized diagnosis of grass -roots psoriasis has a "command stick"

Grass -roots medical care is an important part of my country's medical care system. In order to improve the standardized diagnosis and treatment of psoriasis in primary doctors and county -level medical institutions, the Skin Disease Branch of the Chinese Medical Association, the General Medicine Branch of the Chinese Medical Association, and the China Magazine Society Together, the "Psoriasis Primary Diagnosis and Treatment Guide (2022)" (2022) (hereinafter referred to as the "grass -roots guide") was officially released in the "Chinese General Physician Magazine".

At the press conference, Professor Zhang Xuejun introduced the background, significance and highlights of the "Grassroots Guide" as a project leader. This guide combines the specifications of psoriasis diagnosis and treatment and the reality of grassroots medical care in my country, which systematically introduces the clinical manifestations and diagnosis of typical psoriasis; focusing on explaining the treatment methods with strong operability of grass -roots psoriasis, and not diagnosis of grassroots levels. Clear or refractory referrals for patients with psoriasis; in terms of patient health education, the "Grassroots Guide" supplements the prevention and follow -up measures of psoriasis.

"In the past, due to the lack of standardized clinical operation guidance, many grass -roots doctors did not know much about the basic knowledge of psoriasis, and even dealt with the diagnosis and treatment of conventional skin diseases. These cognition and diagnosis and treatment measures need to be improved." Professor Zhang Xuejun Said, "the" Grassroots Guide "released this time is both practical and scientific. It is an indispensable" command stick "for grass -roots doctors to implement the standardized diagnosis and treatment of psoriasis. Help more county patients get rid of 'silver' shadow and move towards 'new life'. "

In order to facilitate the rapid grasp of and applied precise targeted treatment methods at the grassroots doctors, the "Grassroots Guide" also explained in detail the commonly used biological agents. Professor Zhang Xuejun introduced, "Bai Jiecin biological preparation represented by Zuchu Monopoly has been listed, which greatly expands the choice of drugs for dermatologists to treat psoriasis. In 2020, biological agents were included in national medical insurance, and patients' economic pressure Significantly reduced. With the further coverage of medical insurance, biological preparations are expected to sink to grass -roots medical and health institutions as preferred drugs for psoriasis treatment to benefit a wider range of county patients. "

It is understood that the "Substitute of Slow Disease Management Research", which was led by the Ministry of Dermatology Education's Key Laboratory, also appeared simultaneously in the conference.Professor Zhang Xuejun said, "The meeting has a milestone significance. It marks the focus of my country's psoriasis anti -diagnosis and treatment business began to advance from the city to the grassroots level, and conveys the new concept and new plan for the treatment of silver dedinates to the majority of grassroots hospitals. Looking forward to the great goal of "Qianxian -free" with the efforts of the dermatology department of the grassroots level. "Nanjing Morning News/Ai Nanjing reporter Qi Zaibing

- END -